APOLLO THERAPEUTICS GROUP LIMITED

APOLLO THERAPEUTICS GROUP LIMITED

  • Overview
  • Summary
  • Purpose
  • Address
  • Previous names
  • Accounts
  • Confirmation Statement
  • Filings
  • Officers
  • Persons with significant controls
  • Data Source
  • Overview

    Company NameAPOLLO THERAPEUTICS GROUP LIMITED
    Company StatusActive
    Legal FormPrivate limited company
    Company Number 13393274
    JurisdictionEngland/Wales
    Date of Creation

    Summary

    Has Super Secure PSCsNo
    Has ChargesNo
    Has Insolvency HistoryNo
    Registered Office is in DisputeNo

    What is the purpose of APOLLO THERAPEUTICS GROUP LIMITED?

    • Activities of other holding companies n.e.c. (64209) / Financial and insurance activities

    Where is APOLLO THERAPEUTICS GROUP LIMITED located?

    Registered Office Address
    3rd Floor 22 Station Road
    CB1 2JD Cambridge
    United Kingdom
    Undeliverable Registered Office AddressNo

    What were the previous names of APOLLO THERAPEUTICS GROUP LIMITED?

    Previous Company Names
    Company NameFromUntil
    AT TOPCO LIMITEDMay 13, 2021May 13, 2021

    What are the latest accounts for APOLLO THERAPEUTICS GROUP LIMITED?

    OverdueNo
    Next Accounts
    Next Accounts Period End OnDec 31, 2024
    Next Accounts Due OnSep 30, 2025
    Last Accounts
    Last Accounts Made Up ToDec 31, 2023

    What is the status of the latest confirmation statement for APOLLO THERAPEUTICS GROUP LIMITED?

    Last Confirmation Statement Made Up ToMay 12, 2026
    Next Confirmation Statement DueMay 26, 2026
    Last Confirmation Statement
    Next Confirmation Statement Made Up ToMay 12, 2025
    OverdueNo

    What are the latest filings for APOLLO THERAPEUTICS GROUP LIMITED?

    Filings
    DateDescriptionDocumentType

    Confirmation statement made on May 12, 2025 with updates

    8 pagesCS01

    Cessation of James Momtazee as a person with significant control on Oct 10, 2024

    1 pagesPSC07

    Notification of a person with significant control statement

    2 pagesPSC08

    Statement of capital following an allotment of shares on May 19, 2025

    • Capital: GBP 32,377.2892
    4 pagesSH01

    Director's details changed for Vasundhara Bhargava on Feb 15, 2025

    2 pagesCH01

    Statement of capital following an allotment of shares on Mar 19, 2025

    • Capital: GBP 32,362.9148
    4 pagesSH01

    Statement of capital following an allotment of shares on Oct 08, 2024

    • Capital: GBP 32,308.5732
    4 pagesSH01

    Statement of capital following an allotment of shares on Sep 11, 2024

    • Capital: GBP 32,298.5173
    4 pagesSH01

    Statement of capital following an allotment of shares on Jul 11, 2024

    • Capital: GBP 32,255.1642
    4 pagesSH01

    Group of companies' accounts made up to Dec 31, 2023

    36 pagesAA

    Confirmation statement made on May 12, 2024 with updates

    10 pagesCS01

    Director's details changed for James Momtazee on May 01, 2024

    2 pagesCH01

    Change of details for James Momtazee as a person with significant control on May 01, 2024

    2 pagesPSC04

    Director's details changed for Neel Varshney on May 01, 2024

    2 pagesCH01

    Director's details changed for Ms. Laura Furmanski on May 01, 2024

    2 pagesCH01

    Director's details changed for Vasundhara Bhargava on May 01, 2024

    2 pagesCH01

    Memorandum and Articles of Association

    62 pagesMA

    Resolutions

    Resolutions
    1 pagesRESOLUTIONS
    Resolutions
    CategoryDateDescriptionType
    incorporation

    Resolution of adoption of Articles of Association

    RES01

    Statement of capital following an allotment of shares on Dec 21, 2023

    • Capital: GBP 32,250.6016
    4 pagesSH01

    Statement of capital following an allotment of shares on Dec 06, 2023

    • Capital: GBP 30,219.4603
    4 pagesSH01

    Statement of capital following an allotment of shares on Sep 11, 2023

    • Capital: GBP 28,428.0171
    4 pagesSH01

    Resolutions

    Resolutions
    1 pagesRESOLUTIONS
    Resolutions
    CategoryDateDescriptionType
    capital

    Resolution of removal of pre-emption rights

    RES11
    capital

    Resolution of allotment of securities

    RES10
    capital

    Resolution of varying share rights or name

    RES12
    incorporation

    Resolution of adoption of Articles of Association

    RES01

    Change of share class name or designation

    2 pagesSH08

    Memorandum and Articles of Association

    59 pagesMA

    Termination of appointment of Ian Tomlinson as a director on Jul 13, 2023

    1 pagesTM01

    Who are the officers of APOLLO THERAPEUTICS GROUP LIMITED?

    Officers
    NameAppointed OnResigned OnRoleAddressCompany IdentificationCountry of ResidenceNationalityDate of BirthOccupationNumber
    HEATH, Jamie
    New Street Square
    EC4A 3TW London
    5
    England
    Secretary
    New Street Square
    EC4A 3TW London
    5
    England
    287202000001
    BHARGAVA, Vasundhara
    Sand Hill Road
    Suite 100
    94025 Menlo Park
    2884
    Ca
    United States
    Director
    Sand Hill Road
    Suite 100
    94025 Menlo Park
    2884
    Ca
    United States
    United StatesAmericanVice President284786490002
    FURMANSKI, Laura, Ms.
    Sand Hill Road
    Suite 100
    94025 Menlo Park
    2884
    Ca
    United States
    Director
    Sand Hill Road
    Suite 100
    94025 Menlo Park
    2884
    Ca
    United States
    United StatesAmericanPartner284786500001
    MASON, Richard, Dr
    Gunnels Wood Road
    SG1 2FX Stevenage
    Stevenage Biosciences Catalyst
    England
    Director
    Gunnels Wood Road
    SG1 2FX Stevenage
    Stevenage Biosciences Catalyst
    England
    United KingdomBritishChief Executive Officer284861060001
    MOMTAZEE, James
    Sand Hill Road
    Suite 100
    94025 Menlo Park
    2884
    Ca
    United States
    Director
    Sand Hill Road
    Suite 100
    94025 Menlo Park
    2884
    Ca
    United States
    United StatesAmericanManaging Partner284786280001
    VARSHNEY, Neel
    Sand Hill Road
    Suite 100
    94025 Menlo Park
    2884
    Ca
    United States
    Director
    Sand Hill Road
    Suite 100
    94025 Menlo Park
    2884
    Ca
    United States
    United StatesAmericanDirector283125590001
    WILLIAMS, Sam
    3 Pancras Square
    King’S Cross
    N1C 4AG London
    2nd Floor
    United Kingdom
    Director
    3 Pancras Square
    King’S Cross
    N1C 4AG London
    2nd Floor
    United Kingdom
    United KingdomBritishInvestor294268860001
    TOMLINSON, Ian
    22 Station Road
    CB1 2JD Cambridge
    3rd Floor
    United Kingdom
    Director
    22 Station Road
    CB1 2JD Cambridge
    3rd Floor
    United Kingdom
    United KingdomBritishScientist284860950001

    Who are the persons with significant control of APOLLO THERAPEUTICS GROUP LIMITED?

    Persons with significant controls
    NameNotified OnAddressCeased
    James Momtazee
    Sand Hill Road
    Suite 100
    94025 Menlo Park
    2884
    Ca
    United States
    May 13, 2021
    Sand Hill Road
    Suite 100
    94025 Menlo Park
    2884
    Ca
    United States
    Yes
    Nationality: American
    Country of Residence: United States
    Natures of Control
    • The person holds, directly or indirectly, more than 25% but not more than 50% of the shares in the company.
    • The person holds, directly or indirectly, more than 25% but not more than 50% of the voting rights in the company.
    • The person holds the right, directly or indirectly, to appoint or remove a majority of the board of directors of the company.

    Data Source

    • UK Companies House
      The official register of companies in the UK, providing public access to company information such as names, addresses, directors, and financial filings.
    • license: CC0